Loading...

Japan Tobacco Inc.

2914.TJPX
¥4336.00
¥-81.00(-1.83%)

Japan Tobacco Inc. (2914.T) Stock Overview

Explore Japan Tobacco Inc.’s financial performance, market position, analyst ratings, and future outlook.

Revenue Growth
10.86%
10.86%
Profit Growth
¥261.09
62.84%
EPS Growth
¥261.09
62.84%
Operating Margin
21.77%
3.69%
ROE
11.47%
62.84%
Dividend Yield
0.00%
4.83%
Analyst Recommendations data is not available for 2914.TAnalyst Recommendations details for 2914.T are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Japan Tobacco Inc., a tobacco company, manufactures and sells tobacco products, prescription drugs, and processed foods in Japan and internationally. The company operates through four segments: Domestic Tobacco, International Tobacco, Pharmaceutical, and Processed Food. It offers tobacco products, such as cigarettes, cigars, pipe tobacco, oral tobacco, waterpipe tobacco, kretek, and fine cut products under the Winston, Camel, MEVIUS, and LD brands. The company also provides reduced-risk products, including tobacco-infused vapor and heated tobacco products, E-Vapor products, etc. under the Ploom, Logic, Ploom TECH, Ploom TECH+, and Ploom S brands. In addition, it researches and develops, manufactures, and sells prescription drugs for the therapeutic areas, such as cardiovascular, renal and metabolism, immunology, and neuroscience. Further, the company provides staple food products, such as frozen noodles and okonomiyaki, and frozen and packed cooked rice; ambient processed foods; bakery products; and seasonings, including yeast extracts and oyster sauce. Japan Tobacco Inc. was founded in 1898 and is headquartered in Tokyo, Japan.

CEO

Mr. Masamichi Terabatake

Employees

53,593

Headquarters

1-1, Toranomon 4-chome, Tokyo

Founded

2000

Frequently Asked Questions